EUR 8.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 9.38 Million EUR | -30.67% |
2022 | 13.38 Million EUR | -37.21% |
2021 | 20.08 Million EUR | 25.54% |
2020 | 15.89 Million EUR | 154.26% |
2019 | 5.91 Million EUR | 49.16% |
2018 | 4.54 Million EUR | -2.14% |
2017 | 4.57 Million EUR | -7.62% |
2016 | 4.66 Million EUR | -0.33% |
2015 | 4.73 Million EUR | 50.4% |
2014 | 2.97 Million EUR | 27.89% |
2013 | 2.32 Million EUR | 16.35% |
2012 | 2.32 Million EUR | -18.5% |
2011 | 2.81 Million EUR | 19.43% |
2010 | 1.98 Million EUR | -14.02% |
2009 | 2 Million EUR | 114.9% |
2008 | 1.11 Million EUR | 27.23% |
2007 | 874.43 Thousand EUR | -66.07% |
2006 | 2.57 Million EUR | 32.94% |
2005 | 1.36 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 3.41 Million EUR | 0.0% |
2023 FY | - EUR | -30.67% |
2023 Q4 | 4.26 Million EUR | 0.0% |
2023 Q2 | 3.5 Million EUR | 0.0% |
2022 Q2 | 5.73 Million EUR | 0.0% |
2022 FY | - EUR | -37.21% |
2022 Q4 | 7.68 Million EUR | 0.0% |
2021 FY | - EUR | 25.54% |
2021 Q4 | 8.27 Million EUR | 0.0% |
2021 Q2 | 10.96 Million EUR | 0.0% |
2020 Q4 | 10.73 Million EUR | 0.0% |
2020 Q2 | 4.93 Million EUR | 0.0% |
2020 FY | - EUR | 154.26% |
2019 FY | - EUR | 49.16% |
2019 Q4 | 3.45 Million EUR | 0.0% |
2019 Q2 | 2.8 Million EUR | 0.0% |
2018 Q4 | 2.82 Million EUR | 0.0% |
2018 FY | - EUR | -2.14% |
2018 Q2 | 1.2 Million EUR | 0.0% |
2017 FY | - EUR | -7.62% |
2017 Q4 | 2.37 Million EUR | 0.0% |
2017 Q2 | 1.74 Million EUR | 0.0% |
2016 Q4 | 2.76 Million EUR | 0.0% |
2016 Q2 | 1.69 Million EUR | 0.0% |
2016 FY | - EUR | -0.33% |
2015 Q2 | 1.59 Million EUR | 0.0% |
2015 FY | - EUR | 50.4% |
2015 Q4 | 2.87 Million EUR | 0.0% |
2014 Q2 | 1.19 Million EUR | 0.0% |
2014 Q4 | 1.78 Million EUR | 0.0% |
2014 FY | - EUR | 27.89% |
2013 Q2 | 883.23 Thousand EUR | 0.0% |
2013 Q4 | 1.44 Million EUR | 0.0% |
2013 FY | - EUR | 16.35% |
2012 Q3 | 545.69 Thousand EUR | 0.0% |
2012 FY | - EUR | -18.5% |
2012 Q4 | 545.69 Thousand EUR | 0.0% |
2011 FY | - EUR | 19.43% |
2010 FY | - EUR | -14.02% |
2010 Q2 | 399 Thousand EUR | 0.0% |
2009 Q2 | 403.15 Thousand EUR | 0.0% |
2009 FY | - EUR | 114.9% |
2008 Q2 | 455.1 Thousand EUR | 0.0% |
2008 FY | - EUR | 27.23% |
2007 FY | - EUR | -66.07% |
2006 FY | - EUR | 32.94% |
2005 FY | - EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
CompuGroup Medical SE & Co. KGaA | 215.84 Million EUR | 95.653% |
MeVis Medical Solutions AG | 5.12 Million EUR | -82.908% |
Nexus AG | 53.43 Million EUR | 82.44% |